The impact of meningeal dissemination in primary CNS lymphoma (PCNSL) is debated, and the reported frequency varies. We prospectively evaluated the diagnostic value of PCR in comparison with CSF cytomorphology and MRI for diagnosing meningeal dissemination in PCNSL.
Primary CNS lymphoma (PCNSL) is rare subtype of extranodal non-Hodgkin lymphoma (NHL) confined to the CNS in the absence of systemic disease. Most cases are classified as diffuse large B-cell lymphoma. 1 PCNSL is characterized by a poor prognosis as compared to systemic NHL with similar histology. 2, 3 Several clinical risk factors have been identified in PCNSL, with performance status and age being the most powerful ones. 4, 5 The prognostic impact of meningeal dissemination in PCNSL is unclear.
The morphologic assessment of CSF is considered the gold standard in detecting meningeal dissemination in malignant disease 6 ; however, it fails to demonstrate malignant cells in up to 41% of patients in whom leptomeningeal disease is thought to be present. 7, 8 The frequent false negative results are most often due to the paucity of tumor cells, which in part might be overcome by obtaining large CSF sample volumes and repeated sampling. 6, 9 On the other hand, in contrast to solid tumors, lymphoma cells may sometimes hardly be distinguished from reactive CSF lymphocytes, leading to false positive results. Furthermore, the frequent upfront use of corticosteroids in patients with symptomatic brain tumors represents another obstacle for the detection of lymphoma cells. [10] [11] [12] CSF protein often is cited as adjuvant measurement, but its specificity for meningeal dissemination in PCNSL is low. 13 The sensitivity of radiologic detection of meningeal dissemination, ideally using MRI, is reported considerably lower in lymphoma as compared to solid tumors. 14, 15 It can be speculated that a more sensitive diagnostic method like PCR can enhance the diagnostic accuracy for detection of meningeal dissemination. Its value has not been systematically evaluated in a representative collective of patients with PCNSL thus far.
We present the first prospective comparison of the diagnostic value of CSF cytomorphology, PCR of the rearranged immunoglobulin heavychain (IgH) genes, and MRI in conjunction with cell count and protein concentration for the detection of meningeal dissemination in patients with PCNSL treated in a large multicenter study.
METHODS Patients and treatment. Between 2001 and
June 2007, immunocompetent patients with PCNSL enrolled into a German multicenter prospective randomized trial (G-PCNSL-SG1) were evaluated for the presence of meningeal dissemination by CSF examination (figure 1). For participating institutions, a neuro-oncologic experience was required. 16 Approval for this study was obtained from the institutional ethics committee. Inclusion criteria were immunocompetent patients with histologically or cytologically confirmed PCNSL, age 18 years or older, no previous therapy for PCNSL except corticosteroids, Karnofsky Performance Status (KPS) Ͼ30% due to PCNSL or Ͼ50% due to comorbidities, a creatinine clearance of at least 50 mL/min, and written informed consent. All patients had cranial and, if clinically indicated, additionally spinal gadolinium MRI prior to therapy; FLAIR MRI was not routinely performed. Systemic lymphoma manifestations were excluded by CT of thorax and abdomen and a bone marrow biopsy. All patients were checked for intraocular spread by slit lamp examination.
Primary therapy was not influenced by the diagnosis of meningeal dissemination, and consisted of six cycles HDMTX 4 g/m 2 IV over 4 hours every 2 weeks with a dose adjustment for creatinine clearance (CC) below 100 mL/min (CC/100 * 4 g/m 2 ) prior to every course. Patients were randomized to receive immediate whole brain irradiation (WBI) with 45 Gy (1.5 Gy fractions) or WBI at relapse in case of complete remission (CR) after HDMTX, or to receive high-dose cytarabine 2 ϫ 3 g/m 2 / day IV over 2 days every 3 weeks up to 4 cycles or salvage WBI in case of no CR. CSF analysis. CSF was obtained by lumbar puncture before treatment and evaluated using standard methods for cell count, cytomorphology, and protein immediately after sampling at the treating institution. Each case was interpreted by an experienced hematopathologist or neurologist. Normal values were defined as follows: CSF cells Յ5/L and CSF protein Յ45 mg/dL. CSF
Figure 1
Flow diagram of eligible patients cytology was termed positive for conclusive detection of lymphoma cells and suspicious when atypical lymphatic cells not clearly diagnostic of malignancy were detectable; the remaining cases were termed negative. A sample of 1.5 to 5 mL (median 3.5 mL) of native CSF was sent overnight at room temperature to our central molecular genetics laboratory for PCR examination. Here, DNA was extracted from cell pellets after centrifugation at the day of arrival using commercially available kits. DNA then was stored at Ϫ20°C until PCR analysis. All DNA extracts were controlled for their suitability as templates for IgH PCR by determination of the quantity (NanoDrop) and the quality (human growth hormone [HGH] PCR as control).
Until March 2006, PCR of the rearranged IgH genes (figure 2) was performed as described recently. 17 Briefly, a seminested PCR of the IgH chain CDR3 region was performed using the primers LJH in the first, VLJH in the second, and FR3A in both PCR reactions. 17 From April 2006 to June 2007, 18 samples were subjected to a PCR using three sets of family-specific IgH primers according to the BIOMED-2 protocol, which was modified to apply 50 instead of 35 cycles for increased sensitivity. Three different framework region primer sets (FR1, FR2, and FR3) were applied separately to all samples in conjunction with a IgH joining segment (JH) consensus primer (JH22). 18, 19 In each PCR, positive (DNA from a B-cell line) and negative controls (sterile water) were included. All specimens were amplified at least twice in independent PCR runs to avoid false monoclonal interpretation of pseudoclonal rearrangement patterns. 20 PCR products were subjected to an automated fluorescent fragment analysis. A monoclonal pattern was defined as the detection of a single or dominating amplicon of identical size in repetitive experiments. Multiple peaks characterized polyclonality. Patients with T-NHL were excluded from the PCR analysis.
Neuroimaging. Brain MRIs were obtained before treatment and locally reviewed by an experienced neuroradiologist. A central neuroradiologic reference review was available.
All examinations included T1-and T2-weighted sequences as well as contrast-enhanced studies. Cerebral imaging was performed on various MR scanners with field strengths of 1.0 to 1.5 T. For the T1weighted scans, all patients received 0.1 mmol gadolinium-DTPA per kg body weight. Meningeal dissemination on MRI was defined as contrast enhancement of the leptomeninges.
Statistics. The software package SPSS for Windows release 14.0.1 was used for the statistical evaluation. A descriptive analysis of qualitative and quantitative variables was performed and frequencies, median values, and ranges given when applicable. The 2 test was used to detect correlations between clinical and laboratory variables and the presence of meningeal dissemination and to inspect the missing patterns of the several diagnostic approaches.
The diagnostic value of CSF pleocytosis and elevated protein was assessed using logistic regression, and the OR for meningeal dissemination detection was calculated including the two-sided 95% CI. Additionally, Kappa measures were calculated for each pair of MRI, PCR, and CSF.
RESULTS Patients and samples.
A total of 282 patients were evaluated for the presence of meningeal dissemination: 205 with CSF cytomorphology, 171 with IgH PCR from CSF (figure 1), and 217 with MRI; in 102 patients all three diagnostic methods were performed. The CSF samples were sent by 49 centers, including 20 university and 14 teaching hospitals accounting for 243 (86%) of the samples.
The median age of the patients was 62 (19 -81) years, the median Karnofsky Performance Index 70% (30 -100%). There were 162 (57%) men and 120 women. The histologic diagnosis was diffuse large B cell lymphoma in 272 (97%) patients, small B cell lymphoma in 9 (3%), and T-cell lymphoma in 1 (0.3%) patient. An ocular involvement was found in 8 of 154 (5%) patients examined. Data on pretreatment with corticosteroids at the time of CSF sampling were available for 124 patients (44%); of those, only 14 (11.3%) patients were not on steroids.
Detection of meningeal dissemination by CSF cytomorphology and PCR. Lymphoma cells were detected in 33 of 205 (16.1%) patients tested. A suspicious CSF cytology was found in 20 patients (9.8%), a negative cytology in 152 (74%). A monoclonal PCR product was detected in 19 of 171 samples (11.1%), a polyclonal product in 113 (figure 3). In 39 (22.8%) samples, no IgH PCR product was detectable, in 7 of those (4%) the HGH control PCR was also negative (termed as PCR failure in both cases). Figure 1 shows the results of the molecular genetic analysis of 171 patients with CSF cytomorphology as reference standard.
PCR was monoclonal in 6 of 19 samples (31.6%) with positive, 1 of 13 (7.7%) with suspicious, and in 10 of 105 (9.5%) with negative cytomorphology. In 11 of 19 (57.9%) cytomorphologically positive samples and in 12 of 13 (92.3%) with suspicious cytomorphology, PCR showed only a polyclonal pattern. There were no significant differences concerning meningeal dissemination detection rate and PCR failure between both PCR protocols used. A positive cytomorphology was found in 15 of 94 (16%) patients on steroids vs 2 of 12 (17%) patients without steroids. PCR was monoclonal in 13 of 110 (12%) patients on steroids as compared to 3 of 14 (21%) patients without steroid pretreatment. The rate of PCR failure was 21% in patients with steroid treatment compared to 7% in those without. All these differences were not significant.
Detection of meningeal dissemination by MRI.
Leptomeningeal enhancement was assessed by MRI in 217 patients; in 8 (4%) meningeal dissemination was detected ( figure 3C ). Of those eight patients, CSF cytomorphology was positive in five of six tested patients and negative in one patient (no cytomorphologic examination in two patients). A monoclonal PCR product was found in two of four patients with meningeal dissemination on MRI (no PCR examination in four patients).
Correlation of meningeal dissemination with laboratory and clinical findings.
There was a significant correlation of CSF cell count with meningeal dissemination defined as a positive result of any of the three methods (table) . Also, a significant correlation was found between CSF cell count and CSF cytomorphology with a cytologic detection of lymphoma cells found in 17 of 74 (23%) patients with CSF pleocytosis as compared to 5 of 94 (5%) in patients with normal CSF cell count (p ϭ 0.001). Abnormal CSF protein did not correlate with meningeal dissemination detection. The detection of lymphoma cells by PCR only did not correlate with CSF pleocytosis, PCNSL localization, or CSF protein. There was no correlation between detection of meningeal dissemination and age, gender, KPS, serum lactate dehydrogenase level, and PCNSL localization (data not shown).
Association of MRI, PCR, and CSF. We found no relationship between missing data from one of the three diagnostic procedures MRI, PCR, and CSF and the results of the other procedures. Thus we calculated pairwise Kappa measures for the MRI vs PCR, MRI vs CSF, and PCR vs CSF for all cases in which data were available. These Kappa measures were rather small, 0.18 (PCR vs CSF, p ϭ 0.068), 0.19 (MRI vs PCR, p ϭ 0.013), and 0.27 (MRI vs CSF, p Ͻ 0.001).
DISCUSSION
The relative frequency of meningeal dissemination in PCNSL reported thus far varies from 16% to 42% depending on the diagnostic procedures applied. 9, 13, 21 The relatively low incidence of meningeal dissemination in our study is comparable to that found in more recent studies. 3, 21, 22 The much higher frequency of 42% reported before resulted probably from the inclusion of patients with meningeal biopsy. 9 Obtaining samples from the leptomeninges, however, is not included in clinical routine in PCNSL. When a positive CSF cytomorphology only was considered, a meningeal dissemination frequency of 26% was found in that study. 9 A 60% rate of meningeal dissemination detected by PCR was reported in a retrospective study of 15 patients with PCNSL. However, multiple CSF samples from patients were evaluated over the course of their disease, including relapse. 23 The introduction of putatively more sensitive methods such as flow cytometric immunophenotyping or PCR may enhance the diagnostic accuracy in detecting malignant cells in CSF. Only limited data are reported on both methods in patients with lymphoma, 17, [23] [24] [25] [26] [27] [28] and there are no data on their systematic prospective evaluation in immunocompetent patients with PCNSL.
In this prospective multicenter study with 49 participating institutions, PCR analysis was only possible in a central laboratory, whereas a central cytomorphologic examination was not regarded practicable. This represents a limitation of our study.
The use of steroids in the majority of patients but also the lack of data on steroid pretreatment in nearly half of the study population are further possible limitations. In PCNSL, diagnostic procedures are often reported to be hampered by corticosteroids due to their lymphocytotoxic effect. Pretreatment with corticosteroids in the majority of patients has also been a problem in all other diagnostic studies on PC-NSL. 9, 17, 23 We found no difference of meningeal dissemination frequency in patients with and without corticosteroids; however, the number of patients without corticosteroid pretreatment might have been too small to detect a significant difference.
Radiologic evaluation of the leptomeninges did not contribute considerably to the diagnostic process in our study, corresponding to findings made by others. 14 We could confirm the predictive value of CSF pleocytosis for meningeal dissemination 13 (both detected by cytomorphology and defined as a positive result of any of the methods used). However, the presence of pleocytosis might have biased the decision to diagnose malignant cells. Interestingly, we did not see a correlation of CSF pleocytosis with a positive PCR result. Elevated CSF protein was not associated with meningeal dissemination in this study. Since it has been reported to have prognostic value in PCNSL, 4 it may rather reflect tumor burden or location without being associated with meningeal dissemination.
The high rate of discordant results of cytomorphology and PCR is the most striking finding of this study. Lymphoma cells were confirmed by PCR in only 32% of cytomorphologically positive samples, whereas polyclonal B cells were detected in 58%.
This might be due to a considerable rate of PCR false negatives. In one study, PCR failed to demonstrate clonality in 23% of biopsy samples of immunohistologically proven PCNSL. 29 As compared to nodal diffuse large B-cell lymphomas, PCNSL have an especially high mutational frequency due to the introduction of further point mutations after Ig gene rearrangement, which can prevent annealing of PCR primers. 30, 31 Corticosteroid pretreatment might have also increased the rate of PCR negatives, since PCR failure was more frequent in patients with corticosteroid pretreatment. However, the presence of false positive cytology results cannot be finally ruled out. Conversely, only 35% of samples with a monoclonal PCR result were recognized cytomorphologically, whereas 59% were not. False positive PCR results due to contamination or misinterpretation of a band from a single B cell as monoclonal (pseudomonoclonality) cannot be ruled out. The latter problem occurs frequently when assessing paucicellular specimens with PCR. 32, 33 We tried to minimize this problem by repeated assessment in independent PCR runs as it has been reported for gastric lymphoma. 34 In the only larger comparable study, which used IgH PCR for meningeal dissemination detection in 68 patients with PCNSL retrospectively, discordant PCR and cytology results were also frequent. 17 Given the limitations inherent in the diagnostic methods used, our results indicate that CSF cytomorphology and IgH PCR should be considered complementary methods for meningeal dissemination detection in PC-NSL. The possible impact of meningeal dissemination detection by PCR and cytology on clinical outcome in our study remains to be evaluated.
